Pearl Freier
@pearlf.bsky.social
From Boston, MA. I'm @pearlf on the other blue-colored place. Founder of Cambridge BioPartners, Inc. I post mostly healthcare-related and biotech-related news items.
Even though Congress approved the funding for NIH: All NIH Oct & November grant application submission deadlines to be rescheduled….no new dates yet. All study sections & council meetings to be rescheduled at some point too. Where is the $ going instead without Congressional approval? #medsky
November 16, 2025 at 4:16 PM
Even though Congress approved the funding for NIH: All NIH Oct & November grant application submission deadlines to be rescheduled….no new dates yet. All study sections & council meetings to be rescheduled at some point too. Where is the $ going instead without Congressional approval? #medsky
HHS Secretary Kennedy's business partner was on the InfoWars/Jones podcast today discussing his "investigation" of FDA-approved vaccines. His "advocacy group" saw a 74% increase in revenue for '24 compared to the previous year—$23M #medsky
November 14, 2025 at 10:58 PM
HHS Secretary Kennedy's business partner was on the InfoWars/Jones podcast today discussing his "investigation" of FDA-approved vaccines. His "advocacy group" saw a 74% increase in revenue for '24 compared to the previous year—$23M #medsky
An update below on detection of polio in wastewater in Hamburg, Germany: #medsky
Update on the wild #polio discovery in Germany: The virus was found in wastewater in Hamburg. @rki.de, the German public health agency, says the virus sequence is very similar to some isolated in Afghanistan, so the likely source was an infected human. (page 10 here: www.rki.de/DE/Aktuelles...)
www.rki.de
November 13, 2025 at 1:38 PM
An update below on detection of polio in wastewater in Hamburg, Germany: #medsky
Potentially the 1st first major innovation in malaria treatment since '99 & ability to kill drug-resistant parasites: Novartis's investigational malaria drug GanLum reportedly had a cure rate of >97% & 85.3 % in Phase 3 clinical trials in 12 African countries www.fiercebiotech.com/biotech/nova...
November 13, 2025 at 1:26 PM
Potentially the 1st first major innovation in malaria treatment since '99 & ability to kill drug-resistant parasites: Novartis's investigational malaria drug GanLum reportedly had a cure rate of >97% & 85.3 % in Phase 3 clinical trials in 12 African countries www.fiercebiotech.com/biotech/nova...
Reposted by Pearl Freier
My thesis advisor Mike Chamberlin passed away last week at his home in Berkeley. I've reflected on what I learned from him and how it has served me for over forty years.
Thanks to @lifescivc.bsky.social for hosting the post on his Life Sci VC site.
Thanks to @lifescivc.bsky.social for hosting the post on his Life Sci VC site.
Everything I Know I Learned In Graduate School - LifeSciVC
By Mike Gilman, serial entrepreneur and veteran biotech executive, as part of the From The Trenches feature of LifeSciVC My thesis advisor, Mike Chamberlin, passed away last week. I owe much of who I ...
lifescivc.com
November 7, 2025 at 12:45 PM
My thesis advisor Mike Chamberlin passed away last week at his home in Berkeley. I've reflected on what I learned from him and how it has served me for over forty years.
Thanks to @lifescivc.bsky.social for hosting the post on his Life Sci VC site.
Thanks to @lifescivc.bsky.social for hosting the post on his Life Sci VC site.
No mention of the Rare Pediatric Disease Priority Review Voucher program that supported small drug developers working on rare diseases. Is it over? New priority review program seems to be for large companies/manufacturers who already had high visibility within FDA? #biosky
November 7, 2025 at 12:22 AM
No mention of the Rare Pediatric Disease Priority Review Voucher program that supported small drug developers working on rare diseases. Is it over? New priority review program seems to be for large companies/manufacturers who already had high visibility within FDA? #biosky
The average American will be able to lose 395 lbs over the next 12 months according to Dr. Oz at the White House's weight loss drugs press conference. Grocery store clerks & gas station attendants across the US won't be able to recognize Americans from their photo IDs anymore... #medsky
November 6, 2025 at 10:37 PM
The average American will be able to lose 395 lbs over the next 12 months according to Dr. Oz at the White House's weight loss drugs press conference. Grocery store clerks & gas station attendants across the US won't be able to recognize Americans from their photo IDs anymore... #medsky
JP Morgan's CEO explained to @outfrontcnn.bsky.social why they're not making a donation to the president's ballroom. The video clip is circulating on the other blue site but here's a writeup you can read here: malaysia.news.yahoo.com/jpmorgan-bos...
November 6, 2025 at 6:23 PM
JP Morgan's CEO explained to @outfrontcnn.bsky.social why they're not making a donation to the president's ballroom. The video clip is circulating on the other blue site but here's a writeup you can read here: malaysia.news.yahoo.com/jpmorgan-bos...
The FBI's Boston office announced arrests of 2 men who allegedly set off an explosive/roman candle firework in a locker on 4th floor of a Harvard Medical School building in Longwood. They may not have used access cards to get in or to access 4th floor. Story below: www.thecrimson.com/article/2025...
November 4, 2025 at 8:14 PM
The FBI's Boston office announced arrests of 2 men who allegedly set off an explosive/roman candle firework in a locker on 4th floor of a Harvard Medical School building in Longwood. They may not have used access cards to get in or to access 4th floor. Story below: www.thecrimson.com/article/2025...
An update on biotech investor Tom Brady & Colossal Biosciences: people.com/tom-brady-cl... #biosky
November 4, 2025 at 7:17 PM
An update on biotech investor Tom Brady & Colossal Biosciences: people.com/tom-brady-cl... #biosky
Are Tang & Aurinia Pharma one of the first biopharma companies to publicly reject alleged threats by an HHS/FDA official in '25 by moving forward with a lawsuit? I don't know if Tylenol/Kenvue has filed a lawsuit yet #biosky #medsky
More from @statnews.com on a lawsuit against FDA official Tidmarsh by Aurinia Pharma. @adamfeuerstein.bsky.social tweet said lawsuit accuses Tidmarsh of trying to extort $ from American Laboratories & Kevin Tang. Link to the updated story re: Tidmarsh/FDA www.statnews.com/2025/11/02/f... #biosky
November 3, 2025 at 12:48 AM
More from @statnews.com on a lawsuit against FDA official Tidmarsh by Aurinia Pharma. @adamfeuerstein.bsky.social tweet said lawsuit accuses Tidmarsh of trying to extort $ from American Laboratories & Kevin Tang. Link to the updated story re: Tidmarsh/FDA www.statnews.com/2025/11/02/f... #biosky
November 3, 2025 at 12:30 AM
More from @statnews.com on a lawsuit against FDA official Tidmarsh by Aurinia Pharma. @adamfeuerstein.bsky.social tweet said lawsuit accuses Tidmarsh of trying to extort $ from American Laboratories & Kevin Tang. Link to the updated story re: Tidmarsh/FDA www.statnews.com/2025/11/02/f... #biosky
Reposted by Pearl Freier
Thank you Boston Globe.
h/t @pearlf.bsky.social for catching this.
h/t @pearlf.bsky.social for catching this.
September 22, 2025 at 10:45 PM
Thank you Boston Globe.
h/t @pearlf.bsky.social for catching this.
h/t @pearlf.bsky.social for catching this.
Reposted by Pearl Freier
IT would be helpful for everyone if y'all could do one simple thing: Quit trying to ascribe logic to these people. Quit attempting to explain their actions and statement through a lens of rationality. Start using words like, "lie", "unacceptable", "false", "unqualified", "junk science".
September 19, 2025 at 5:52 PM
IT would be helpful for everyone if y'all could do one simple thing: Quit trying to ascribe logic to these people. Quit attempting to explain their actions and statement through a lens of rationality. Start using words like, "lie", "unacceptable", "false", "unqualified", "junk science".
If there's an Ebola and/or bird flu outbreak among humans in the US, the "experts" who spoke at today's WH press conference on autism are currently in charge of responding to infectious disease outbreaks. #medsky
September 22, 2025 at 9:54 PM
If there's an Ebola and/or bird flu outbreak among humans in the US, the "experts" who spoke at today's WH press conference on autism are currently in charge of responding to infectious disease outbreaks. #medsky
Reposted by Pearl Freier
I watched 7 hours of yesterday's ACIP meeting so you didn't have to.
www.wired.com/story/vaccin...
www.wired.com/story/vaccin...
Vaccine Panel Stacked by RFK Jr. Recommends Delaying MMRV Immunization
The vaccine advisory group ACIP, not all members of which seemed to know what the group does, recommended to the CDC that combined MMRV shots not be given before age 4.
www.wired.com
September 19, 2025 at 12:56 PM
I watched 7 hours of yesterday's ACIP meeting so you didn't have to.
www.wired.com/story/vaccin...
www.wired.com/story/vaccin...
AI & biopharma: speakers from Pfizer, Novartis, the Broad, Vertex & Formation Bio will discuss some key areas where biopharma industry has been successful in developing & applying AI & they're giving career advice on Boston panel tomorrow/Friday. harvardbiotechclub.typeform.com/to/YoaosYwk?...
September 18, 2025 at 9:25 PM
AI & biopharma: speakers from Pfizer, Novartis, the Broad, Vertex & Formation Bio will discuss some key areas where biopharma industry has been successful in developing & applying AI & they're giving career advice on Boston panel tomorrow/Friday. harvardbiotechclub.typeform.com/to/YoaosYwk?...
Biogen is buying Alcyone for $85M upfront to advance ThecaFlex DRx, implantable subcutaneous port & catheter device being investigated 4 better delivery of antisense oligonucleotides (ASOs) 4 neuro diseases incl SMA patients—alternative 2repeat lumbar punctures www.biopharmadive.com/news/biogen-...
September 18, 2025 at 9:19 PM
Biogen is buying Alcyone for $85M upfront to advance ThecaFlex DRx, implantable subcutaneous port & catheter device being investigated 4 better delivery of antisense oligonucleotides (ASOs) 4 neuro diseases incl SMA patients—alternative 2repeat lumbar punctures www.biopharmadive.com/news/biogen-...
Reposted by Pearl Freier
September 18, 2025 at 5:23 PM
Reposted by Pearl Freier
Freelance illustration gigs drying up. Ad agencies using Midjourney instead of hiring human artists. Costume design turned over to AI wholesale. Good work vanishing.
These are the stories of working visual artists, who describe losing jobs, wages, and hope as their clients and bosses embrace AI.
These are the stories of working visual artists, who describe losing jobs, wages, and hope as their clients and bosses embrace AI.
Artists are losing work, wages, and hope as bosses and clients embrace AI
Visual artists, illustrators and graphic designers share their stories about how AI is being used to lower wages, degrade work and even replace it altogether, in this installment of AI Killed My Job.
www.bloodinthemachine.com
September 17, 2025 at 5:01 PM
Freelance illustration gigs drying up. Ad agencies using Midjourney instead of hiring human artists. Costume design turned over to AI wholesale. Good work vanishing.
These are the stories of working visual artists, who describe losing jobs, wages, and hope as their clients and bosses embrace AI.
These are the stories of working visual artists, who describe losing jobs, wages, and hope as their clients and bosses embrace AI.
Reposted by Pearl Freier
Margaret Chu-Moyer & her team at Amgen were honored by @acs.org @cenmag.bsky.social as "2025 Heroes of Chemistry" & FDA-approved drug Lumakras "targeted therapy that treats patients with advanced KRAS G12C–mutated NSCLC". She's speaking on Friday's panel in Boston cc @chemjobber.bsky.social #chemsky
BMS EVP & Chief Research Officer Robert Plenge,
NVS VP & Head of Data42 Birgit Schoeberl, Amgen's VP & Head of Small Molecule Therapeutic Discovery Margaret Chu-Moyer, Sanofi's VP & Head Ophthalmology Rrch Anneke den Hollander on 9/19 1:30 Harvard Med School panel www.thebiotechclub.org/career-fair
NVS VP & Head of Data42 Birgit Schoeberl, Amgen's VP & Head of Small Molecule Therapeutic Discovery Margaret Chu-Moyer, Sanofi's VP & Head Ophthalmology Rrch Anneke den Hollander on 9/19 1:30 Harvard Med School panel www.thebiotechclub.org/career-fair
September 17, 2025 at 8:17 PM
Margaret Chu-Moyer & her team at Amgen were honored by @acs.org @cenmag.bsky.social as "2025 Heroes of Chemistry" & FDA-approved drug Lumakras "targeted therapy that treats patients with advanced KRAS G12C–mutated NSCLC". She's speaking on Friday's panel in Boston cc @chemjobber.bsky.social #chemsky
BMS EVP & Chief Research Officer Robert Plenge,
NVS VP & Head of Data42 Birgit Schoeberl, Amgen's VP & Head of Small Molecule Therapeutic Discovery Margaret Chu-Moyer, Sanofi's VP & Head Ophthalmology Rrch Anneke den Hollander on 9/19 1:30 Harvard Med School panel www.thebiotechclub.org/career-fair
NVS VP & Head of Data42 Birgit Schoeberl, Amgen's VP & Head of Small Molecule Therapeutic Discovery Margaret Chu-Moyer, Sanofi's VP & Head Ophthalmology Rrch Anneke den Hollander on 9/19 1:30 Harvard Med School panel www.thebiotechclub.org/career-fair
September 17, 2025 at 8:07 PM
BMS EVP & Chief Research Officer Robert Plenge,
NVS VP & Head of Data42 Birgit Schoeberl, Amgen's VP & Head of Small Molecule Therapeutic Discovery Margaret Chu-Moyer, Sanofi's VP & Head Ophthalmology Rrch Anneke den Hollander on 9/19 1:30 Harvard Med School panel www.thebiotechclub.org/career-fair
NVS VP & Head of Data42 Birgit Schoeberl, Amgen's VP & Head of Small Molecule Therapeutic Discovery Margaret Chu-Moyer, Sanofi's VP & Head Ophthalmology Rrch Anneke den Hollander on 9/19 1:30 Harvard Med School panel www.thebiotechclub.org/career-fair